| 0 (0%) | 11-11 19:22 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 48.12 |
1-year : | 56.2 |
| Resists | First : | 41.2 |
Second : | 48.12 |
| Pivot price | 28.28 |
|||
| Supports | First : | 31.72 |
Second : | 25.87 |
| MAs | MA(5) : | 29.8 |
MA(20) : | 28.2 |
| MA(100) : | 31.63 |
MA(250) : | 32.55 |
|
| MACD | MACD : | 0.4 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 61 |
D(3) : | 44.3 |
| RSI | RSI(14): 83.8 |
|||
| 52-week | High : | 41.2 | Low : | 25.87 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ SRDX ] has closed It is unclear right now based on current values. 224.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 41.25 - 41.41 | 41.41 - 41.57 |
| Low: | 40.21 - 40.4 | 40.4 - 40.59 |
| Close: | 40.63 - 40.92 | 40.92 - 41.22 |
Tue, 11 Nov 2025
Surmodics Stock Soars Amid Positive Registry Study Results and Court Ruling - StocksToTrade
Tue, 11 Nov 2025
Why Is Surmodics Stock Soaring Today? - Surmodics (NASDAQ:SRDX) - Benzinga
Tue, 11 Nov 2025
GTCR can proceed with Surmodics acquisition after court denies FTC’s attempt to block it - MassDevice
Tue, 11 Nov 2025
Surmodics Gains Momentum with Promising Thrombectomy Results and Acquisition Progress - timothysykes.com
Tue, 11 Nov 2025
Surmodics jumps after US judge rejects FTC's bid to block acquisition by GTCR - TradingView
Tue, 11 Nov 2025
Surmodics (SRDX) Surges After Court Clears Path for GTCR Acquisi - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 14 (M) |
| Shares Float | 12 (M) |
| Held by Insiders | 3.4 (%) |
| Held by Institutions | 90.3 (%) |
| Shares Short | 400 (K) |
| Shares Short P.Month | 333 (K) |
| EPS | -1.25 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.78 |
| Profit Margin | -14.6 % |
| Operating Margin | 0.2 % |
| Return on Assets (ttm) | -0.6 % |
| Return on Equity (ttm) | -15.4 % |
| Qtrly Rev. Growth | -2.6 % |
| Gross Profit (p.s.) | 6.43 |
| Sales Per Share | 8.44 |
| EBITDA (p.s.) | 0.49 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -2 (M) |
| Levered Free Cash Flow | 9 (M) |
| PE Ratio | -33.02 |
| PEG Ratio | 0 |
| Price to Book value | 5.26 |
| Price to Sales | 4.84 |
| Price to Cash Flow | -311.41 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|